Recipients › New York › Codagenix Inc
Recipient organisation · UEI TEMNL437K2F1
Codagenix Inc
USAspending caveat. Figures are obligations reported by federal agencies to USAspending.gov, not payments. In USAspending's words: "An outlay occurs when federal money is actually paid out, not just promised to be paid ('obligated')." "Every agency has a Senior Accountable Official who must officially certify that the quarterly financial data submitted by their agency is accurate and complete." "If there are any discrepancies in procurement data, FPDS is the authoritative source." Contract data for the Department of Defense and the U.S. Army Corps of Engineers is published with a 90-day delay. Data loaded 30 Sep 2026. View the USAspending recipient profile.
Codagenix Inc, of Farmingdale, NY, was obligated $16M in federal awards across the 1 fiscal year in which it reached the $1.0M listing floor (2023).
Codagenix Inc ranks 960 of 1,532 listed organisations located in NY by five-year obligations, and 20,842 of 30,000 nationally.
Its $1.0M-plus awards since FY2023 came from Department of Health and Human Services and Department of Defense: 2 awards worth $16M in total award value.
Its largest contract industry is NAICS 541714 (Research and Development in Biotechnology (except Nanobiotechnology)), where it ranks 74 of 180 organisations by the value of $1.0M-plus awards.
Obligations by fiscal year contracts vs assistance
| Fiscal year | All obligations | Contracts | Assistance | Change |
|---|---|---|---|---|
| FY2023 | $15,880,000 | $10,000,000 | $5,880,000 | — |
| FY2024 | under $1.0M | — | — | — |
| FY2025 | under $1.0M | — | — | — |
| FY2026 | under $1.0M | — | — | — |
| FY2027 to date | under $1.0M | — | — | — |
A fiscal year runs 1 October to 30 September. "Contracts" are procurement award types A–D; "assistance" is everything else (grants, direct payments, loan subsidy cost, insurance, other). The contracts column is listed only where contract obligations alone reached $1.0M; the assistance figure is the remainder and may therefore include up to $1.0M of contracts.
Compared with its state and the largest recipients five listed years
| Measure | This organisation | Largest in NY | Largest nationally |
|---|---|---|---|
| Five-year obligations (listed years) | $16M | $279B | $416B |
| FY2026 obligations | under $1.0M | $75B | $118B |
| Contracts, five years | $10M | under $1.0M | $94B |
| Assistance, five years | $5.9M | $279B | $416B |
| Rank by five-year obligations | 20,842 of 30,000 | 1 of 1,532 in NY | 1 |
Largest in state: NYS Department of Health. Largest nationally: Health Care Services, California Department of. Rankings count organisations located in the state, by the sum of their listed fiscal years.
Awarding agencies $1.0M+ awards since FY2023
| # | Agency | Awards | Award value | Share |
|---|---|---|---|---|
| 1 | Department of Health and Human Services | 1 | $10M | 63% |
| 2 | Department of Defense | 1 | $5.9M | 37% |
Contract industries NAICS
Rank within NAICS 541714: 74 of 180 organisations by $1.0M+ award value; see Research and Development in Biotechnology (except Nanobiotechnology).
Assistance programs listings
Places of performance $1.0M+ awards
Counties: Suffolk County, NY $16M
Largest awards begun since FY2023
| Awarding agency | Type | Industry or program | Award value | Begun | Place | Record |
|---|---|---|---|---|---|---|
| Department of Health and Human ServicesOffice of Assistant Secretary for Preparedness and Response | ContractDefinitive Contract | 541714 Research and Development in Biotechnology (except Nanobiotechnology) | $10M | 27 Sep 2023 | NY | USAspending |
| Department of DefenseDefense Health Agency | GrantCooperative Agreement (B) | 12.420 Military Medical Research and Development | $5.9M | 22 Sep 2023 | NY | USAspending |
Award value is the amount obligated to the award to date as USAspending reports it. Descriptions below are USAspending's text, unedited and truncated; those that appear to name a person are withheld.
- $10M, Department of Health and Human Services, 27 Sep 2023: CONDUCT A PHASE 2B EFFICACY STUDY AS PRESCRIBED IN AOI15 WITH COVILIV A PROPRIETARY LIVE ATTENUATED VIRUS COVID-19 VACCINE.
- $5.9M, Department of Defense, 22 Sep 2023: GMP MANUFACTURING AND INITIAL CLINICAL EVALUATION OF A TETRAVALENT LIVE ATTENUATED DENGUE VACCINE
Questions and answers
How much federal money does Codagenix Inc receive?
$16M in award obligations over the fiscal years it is listed for (FY2023: $16M). Years not listed were under the $1.0M floor. Obligations are binding commitments, not payments made.
Which agencies award to Codagenix Inc?
By the value of $1.0M-plus awards begun since FY2023: Department of Health and Human Services ($10M) and Department of Defense ($5.9M).
What is the money for?
Contracts are classified under NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology). Assistance falls under Military Medical Research and Development (12.420).
Where is the work performed?
Primary places of performance for its larger awards: NY ($16M).
Is Codagenix Inc a large federal recipient?
It ranks 20,842 of 30,000 organisations on this site by five-year obligations and 960 of 1,532 located in NY. The site covers organisations with at least $1.0M in a fiscal year; individuals are excluded.
Where does this data come from?
USAspending.gov (U.S. Treasury), award transactions as loaded on 30 Sep 2026; fiscal-year totals via the spending-by-category endpoint and award lists via the award search endpoint. The USAspending recipient profile is the authoritative record.
Provenance
Source: USAspending.gov API v2 (U.S. Department of the Treasury, Bureau of the Fiscal Service), CC0. Fiscal-year obligations from the spending-by-category recipient ranking by recipient state (listing floor $1.0M per year); awards from the award search endpoint (new awards of $1.0M or more by base obligation date); parent and business categories from the recipient profile where fetched. Closed fiscal years are snapshots taken after year end; FY2027 is refreshed on each build. Data loaded by USAspending on 30 Sep 2026. Individuals and sole proprietors are excluded at ingest. Errors in processing are corrected at the next build; see corrections and the methodology.